Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation
Main Authors: | A. Burls, W. Clark, T. Stewart, C. Preston, S. Bryan, T. Jefferson, A. Fry-Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2002-01-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta6090 |
Similar Items
-
Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation
by: P Tappenden, et al.
Published: (2009-02-01) -
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
by: Y-F Chen, et al.
Published: (2006-11-01) -
Intravenous zanamivir for influenza myocarditis and enteral malabsorption
by: Fritz-Patrick Jahns, et al.
Published: (2018-12-01) -
Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
by: W. Clark, et al.
Published: (2003-01-01) -
Population Pharmacokinetic/Pharmacodynamic Analysis of Intravenous Zanamivir in Healthy Adults and Hospitalized Adult and Pediatric Subjects With Influenza
by: Peiying Zuo, et al.
Published: (2020-01-01)